Tilray Officially Announces Pricing for NASDAQ IPO | CashCropToday
0 Shares 573 Views

Tilray Officially Announces Pricing for NASDAQ IPO

July 19, 2018
573 Views

Tilray, Inc., wholly owned subsidiary of private company Privateer Holdings, Inc., has officially announced this week pricing on its NADAQ initial public offering of the company’s stock.

Tilray is a global medicinal cannabis researcher, cultivator, processor, and distributer of finished product. The company prides itself on its vertically integrated business model and scientifically driven manufacturing techniques. The company sells a number of different products that include THC, CBD, and a blend of both cannabinoids in the form of cannabis flower and other extracts.

The company will offering 9,000,000 shares of Class 2 common stock. 6,524,000 will be sold in the U.S. and 2,476,000 shares to be sold in Canada at $17.oo a share. Based on the exchange rate between the two countries Tilray expects the IPO to raise the company a total of  US$153,000,000.00

Tilray will begin trading on the Nasdaq Global Market Exchange under the ticker symbol TLRY. The company has successfully completed its registration statement on Form S-1 and the SEC has approved the offering. Cowen and BMO Capital Markets are acting jointly as book-runners for the IPO.

You may be interested

Cash Crop Today Interview with David Boissinot from Trimpro
Market Watch
3 views
Market Watch
3 views

Cash Crop Today Interview with David Boissinot from Trimpro

Editor - October 23, 2018

Trimpro developes and manufactures top of the line, full service, trimming machines in Canada which can be shipped to growers throughout the world. The following is a…

OTC Markets Group Welcomes TerrAscend Corp. to OTCQX
Market Watch
20 views
Market Watch
20 views

OTC Markets Group Welcomes TerrAscend Corp. to OTCQX

Jaelynn Offerman - October 22, 2018

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced TerrAscend Corp. (CSE: TER; OTCQX: TRSSF), a biopharmaceutical and wellness company that…

Pivot Pharmaceuticals Signs Agreement with Licorera Del Sur Subsidiary Cartagena Inc. To Create Joint Venture To Commercialize Cannabis-Infused Non-Alcoholic Beverages
Global
11 views
Global
11 views

Pivot Pharmaceuticals Signs Agreement with Licorera Del Sur Subsidiary Cartagena Inc. To Create Joint Venture To Commercialize Cannabis-Infused Non-Alcoholic Beverages

Jaelynn Offerman - October 22, 2018

Pivot Pharmaceuticals, Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Letter of Intent to create a Joint Venture…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: